Pharmacological modulation of lung cancer cells for potassium ion depletion

Britta Andersson1, Parviz Behnam-Motlagh, Roger Henriksson

  • 1Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.

Anticancer Research
|August 6, 2005
PubMed
Abstract

Insights

Pharmacologically depleting cancer cells of potassium (K+) is achievable. Combining influx inhibitors with efflux stimulators effectively reduces intracellular K+ for apoptosis studies.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Pharmacology

Background:

  • Intracellular potassium ion (K+) depletion is crucial for apoptosis.
  • Apoptotic features include cell shrinkage, DNA fragmentation, and caspase activation.

Purpose of the Study:

  • To investigate pharmacological methods for depleting K+ in human pulmonary mesothelioma (P31) and small cell lung cancer (U1690) cells.
  • To assess the potential for K+ depletion in future apoptosis induction studies.

Main Methods:

  • Utilized 86Rubidium (86Rb+) as a K+ analogue to measure ion transport.
  • Employed Na+, K+, 2Cl(-)-cotransport inhibitor bumetanide and Na+, K+-ATPase pump inhibitor ouabain to inhibit K+ influx.
  • Used amphotericin B, digitonin, and nigericin to stimulate K+ efflux.

Main Results:

  • Combined bumetanide and ouabain markedly and persistently inhibited 86Rb+ influx (up to 6 hours).
  • Amphotericin B, digitonin, and nigericin augmented cellular K+ efflux.
  • Amphotericin B showed effective 86Rb+ efflux stimulation with low cytotoxicity, unlike digitonin and nigericin which exhibited significant toxicity.

Conclusions:

  • Efficient reduction of intracellular K+ in cancer cells is feasible.
  • This can be achieved through sustained K+ influx inhibition combined with K+ efflux stimulation.
  • Clinically available drugs can be utilized for this purpose in apoptosis research.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...